RHA 2, RHA 3, RHA 4 dermal fillers

FDA Premarket Approval P170002 S020

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DeviceRHA 2, RHA 3, RHA 4 dermal fillers
Generic NameImplant, Dermal, For Aesthetic Use
ApplicantTEOXANE S.A.rue De Lyon 105geneva 1203 PMA NumberP170002 Supplement NumberS020 Date Received01/31/2022 Decision Date02/24/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Date Received2022-01-31
Decision Date2022-02-24
PMAP170002
SupplementS020
Product CodeLMH 
Advisory CommitteeGeneral & Plastic Surgery
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination ProductYes
Applicant AddressTEOXANE S.A.
rue De Lyon 105
geneva 1203 PMA NumberP170002 Supplement NumberS020 Date Received01/31/2022 Decision Date02/24/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No Combination ProductYes Approval Order Statement  
Removal Of In-process Control (IPC) Tests For PH At Dialysis And Rheology At Filling During The Manufacturing Of RHA 2, RHA 3, And RHA 4

Supplemental Filings

Supplement NumberDateSupplement Type
P170002Original Filing
S025 2022-12-27 30-day Notice
S024
S023
S022
S021 2022-03-17 Real-time Process
S020 2022-01-31 30-day Notice
S019 2021-07-26 Real-time Process
S018 2021-07-16 30-day Notice
S017 2021-04-26 30-day Notice
S016 2021-04-02 30-day Notice
S015 2021-03-29 30-day Notice
S014 2021-03-16 Special (immediate Track)
S013 2021-02-17 30-day Notice
S012
S011
S010 2020-07-20 135 Review Track For 30-day Notice
S009 2020-02-14 30-day Notice
S008 2020-02-13 30-day Notice
S007 2019-11-13 30-day Notice
S006
S005 2019-06-18 Real-time Process
S004 2019-03-12 135 Review Track For 30-day Notice
S003 2019-03-12 30-day Notice
S002 2019-02-21 30-day Notice
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.